title: Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin.
abstract: OBJECTIVE
  To examine older patients' preferences regarding the use of warfarin to prevent atrial fibrillation related strokes when faced with cumulative probabilities of treatment risk and benefit.
  
  
  METHODS
  A semi-qualitative researcher administered questionnaire and interview.
  
  
  METHODS
  81 patients attending a general elderly medicine outpatient clinic.
  
  
  RESULTS
  Up to 50% of participants would decline warfarin treatment when shown both cumulative benefits of stroke risk reduction and risk of intracerebral haemorrhage. Principal themes highlighted concepts of gambling and trade offs relating to risk and benefit. Attitudes about stroke and negative perceptions of intracerebral haemorrhage were major contributory themes in the decision to refuse warfarin treatment.
  
  
  CONCLUSIONS
  Older people use very individualistic health beliefs in judging how to trade risks to preserve quality of life. Carefully explaining risk information and listening to elders' views and reasoning is likely to result in a more informed choice regarding the use of anticoagulation in stroke prevention.
authors.affiliation: Medical Department for the Elderly, The General Infirmary, Leeds LS1 3EX, UK. Ftworf@aol.com
authors.forename: Richard
authors.initials: R
authors.lastname: Fuller
authors.forename: Nigel
authors.initials: N
authors.lastname: Dudley
authors.forename: Jon
authors.initials: J
authors.lastname: Blacktop
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001294:Attitude to Health; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000523:psychology; D005260:Female; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D020521:Stroke / Q000517:prevention & control* / Q000523:psychology*; D011795:Surveys and Questionnaires; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014859:Warfarin